Sarah Boyce Sells 10,397 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CEO Sarah Boyce sold 10,397 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $28.59, for a total value of $297,250.23. Following the transaction, the chief executive officer now directly owns 337,411 shares […]

Leave a Reply

Your email address will not be published.

Previous post SoFi Select 500 ETF (NYSEARCA:SFY) Sees Unusually-High Trading Volume – Still a Buy?
Next post Semrush (NASDAQ:SEMR) Reaches New 12-Month High – Here’s Why